Hoy, I read about issue with cART drugs regime ending and a gene therapy starting. Not full bottle on it. Something like the virus being able to take before the therapy starts, resulting in failure of the therapy.
I wonder of this is an issue for Cal-1? Not sure if this new approach at a functional cure predicts failure of Cal-1?
- Forums
- ASX - By Stock
- Calimmune Gen2
Hoy, I read about issue with cART drugs regime ending and a gene...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online